A phase I/II registration-enabling company-sponsored clinical trial of AVR-RD-04 in cystinosis

Status: Planning

Phase of Trial: Phase I/II

Latest Information Update: 24 Jul 2024

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

20 Jun 2024 According to a Tectonic Therapeutic media release, AVROBIO has been merged with Tectonic Therapeutic to form Tectonic Therapeutic.
23 Mar 2023 According to an AVROBIO media release, the company plans to initiate this registration-enabling study in the second half of 2023, subject to regulatory alignment.
25 Oct 2022 According to an AVROBIO media release, the company is planning for regulatory agency interactions to discuss clinical development and regulatory strategy, with the intent of initiating this company-sponsored trial.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com